Mar 28 |
Here’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)
|
Mar 5 |
C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024
|
Mar 4 |
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
|
Mar 1 |
C4 Therapeutics' TORPEDO Platform Is Promising, But Its Valuation Remains Stretched
|
Feb 27 |
New Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)
|
Feb 24 |
C4 Therapeutics Full Year 2023 Earnings: Misses Expectations
|
Feb 22 |
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
|
Feb 22 |
C4 Therapeutics Inc (CCCC) Reports Full Year 2023 Financial Results and Business Updates
|
Feb 22 |
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
|
Feb 20 |
Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
|